ISR Articles
-
Perspectives On Decentralized Trial Service Providers
5/4/2023
Watch as life science experts discuss key learnings from the second edition of Industry Standard Research’s Decentralized Trial Market Outlook report.
-
Predictive Power Of Perceived Leadership
4/5/2023
Analyze several factors that influence CRO preferences and how much sponsor organizations say preference plays into the CRO selection process.
-
How To Make Your CRO Stand Out Or Find That Perfect Fit
4/5/2023
Explore the myriad facets of the drug development process to gain pertinent information for ensuring successful clinical research outcomes.
-
Considerations When Selecting An Interactive Response Technology Provider
2/9/2023
Interactive response technology (IRT) systems ensure clinical trial participants receive the correct treatment, facilitate enhanced logistics tracking, and empower users to obtain real-time data.
-
Decentralized Clinical Trials: Evolving Post-Pandemic
2/9/2023
Review the findings from a recent market research report on decentralized trials specific to area of investment, eTechnology adoption, and cost predictions.
-
Understanding The Art And Science Of Patient Recruitment
1/23/2023
As clinical trials become increasingly complex, it is more important than ever to understand how to overcome patient recruitment challenges in order to accelerate timelines, lower costs, and improve the quality of clinical trial data.
-
Industry Trends: CDMO Outsourcing
10/5/2022
No single CDMO strategy or outsourcing model is appropriate for every project. Outsourcers can and should evaluate a strategy and partner(s) on a case-by-case basis.
-
Phase II/III Outsourcing Partner Selection Attributes
10/4/2022
In the beginning of 2022, ISR surveyed 132 sponsors worldwide who outsource Phase II/III studies and asked them to identify attributes that are important to them when selecting an outsourcing partner. The research revealed that respondents valued operational excellence and therapeutic expertise highly when choosing a provider for their Phase II/III studies.
-
Understanding The Art And Science Of CRO Selection
9/19/2022
This e-book examines the rationale behind how CROs are selected, why they are retained, and why sponsors opt for one provider or outsourcing model versus another.
-
2022 CRO Leadership Awards Results
9/1/2022
50 CROs were evaluated on more than 20 performance metrics. Research participants were recruited from biopharmaceutical companies of all sizes and were screened for decision-making influence when it comes to working with outsourcing partners. Find out the results in this report.